Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

AI-Assisted Camera-Based Progressive Muscle Relaxation for Office Workers (AI-PMR)

17 de mayo de 2026 actualizado por: dogukan kurc, Istanbul Medipol University Hospital

Effectiveness of an AI-Assisted Camera-Based Progressive Muscle Relaxation Application in Office Workers: A Randomized Controlled Trial

This randomized controlled trial evaluates the effectiveness of an AI-assisted, camera-based progressive muscle relaxation application in office workers aged 20 to 40 years. Participants are randomly allocated to an intervention group or a control group. The intervention group completes a 4-week progressive muscle relaxation program using the PhysioTR Academic application, which provides camera-based real-time movement analysis and exercise guidance. The control group continues their usual daily routine and completes baseline and post-intervention assessments only. Outcomes include pain/tension intensity, musculoskeletal symptoms, perceived stress, neck disability, work productivity, functionality, and AI-based adherence metrics.

Descripción general del estudio

Descripción detallada

This study is a single-center, randomized, controlled, open-label trial conducted in office workers aged 20 to 40 years. Participants are automatically randomized into either an intervention group or a control group.

The intervention group uses the PhysioTR Academic application for a 4-week progressive muscle relaxation program. The program includes 3 sessions per week, 12 sessions in total. Each session includes four exercise components: face and jaw, neck and shoulders, hands and arms, and back and chest. Each exercise includes a contraction and relaxation phase. The application uses the participant's device camera for real-time movement analysis and provides written and/or audio guidance.

The control group continues their usual daily routine and does not receive an exercise intervention during the study period. The control group completes only baseline and post-intervention assessments.

Assessments are performed at baseline and Week 4. Outcome measures include the Visual Analog Scale, Nordic Musculoskeletal Questionnaire, Perceived Stress Scale, Neck Disability Index, Work Productivity Scale, numeric functionality score, and AI-based adherence and landmark coverage metrics in the intervention group.

Tipo de estudio

Intervencionista

Inscripción (Actual)

60

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Beykoz
      • Istanbul, Beykoz, Turquía (Türkiye), 34810
        • Istanbul Medipol University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto

Acepta Voluntarios Saludables

Sí

Descripción

Inclusion Criteria:

  • Aged between 20 and 40 years
  • Actively working in a desk-based or office-based job
  • Having access to a camera-enabled device such as a smartphone or computer
  • Voluntary participation with informed consent
  • Able to read and write Turkish
  • Having a valid e-mail address

Exclusion Criteria:

  • Previous surgery involving the neck or spine
  • Cervical vertebral fracture or instability
  • History of neurological disease such as multiple sclerosis or Parkinson's disease
  • Vestibular system disorder
  • Systemic inflammatory disease such as rheumatoid arthritis or ankylosing spondylitis
  • History of malignancy
  • Pregnancy
  • Having received physiotherapy for the neck or back region within the last 6 months

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Cuidados de apoyo
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: AI-Assisted Camera-Based Progressive Muscle Relaxation Group
Participants in this group complete a 4-week progressive muscle relaxation program using the PhysioTR Academic application. The program includes 3 sessions per week, 12 sessions in total. Each session includes four components: face and jaw, neck and shoulders, hands and arms, and back and chest. The application uses the participant's device camera for real-time movement analysis and records session-level Visual Analog Scale scores and AI-based adherence metrics.
A camera-based progressive muscle relaxation program delivered through the PhysioTR Academic web application. The intervention includes 4 weeks of training, 3 sessions per week, for a total of 12 sessions. The application provides written and/or audio instructions and uses camera-based real-time movement analysis to support exercise performance and adherence monitoring.
Sin intervención: Control Group
Participants in the control group continue their usual daily routine and do not receive an exercise intervention during the study period. They complete baseline and Week 4 assessments only.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in Pain/Tension Intensity Assessed by Visual Analog Scale
Periodo de tiempo: Baseline and Week 4
Pain/tension intensity is assessed using a 0-10 Visual Analog Scale. Higher scores indicate greater pain/tension intensity. Change is calculated from baseline to Week 4.
Baseline and Week 4

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in Musculoskeletal Symptoms Assessed by the Nordic Musculoskeletal Questionnaire
Periodo de tiempo: Baseline and Week 4
Musculoskeletal symptoms are assessed using the Nordic Musculoskeletal Questionnaire across body regions. The outcome is summarized as the presence of symptoms by region and/or the number of symptomatic body regions. Higher values indicate more widespread musculoskeletal symptoms.
Baseline and Week 4
Change in Perceived Stress Scale Score
Periodo de tiempo: Baseline and Week 4
Perceived stress is assessed using the Turkish version of the Perceived Stress Scale. Higher scores indicate greater perceived stress.
Baseline and Week 4
Change in Neck Disability Index Score
Periodo de tiempo: Baseline and Week 4
Neck-related disability is assessed using the Neck Disability Index. Higher scores indicate greater neck-related disability.
Baseline and Week 4
Change in Work Productivity Scale Score
Periodo de tiempo: Baseline and Week 4
Work productivity is assessed using a 5-item Likert-type Work Productivity Scale. Total scores range from 5 to 25, with higher scores indicating higher work productivity.
Baseline and Week 4
Change in Numeric Functionality Score
Periodo de tiempo: Baseline and Week 4
General functionality is assessed using a numeric rating scale from 0 to 10, where 0 indicates very poor functionality and 10 indicates excellent functionality. Higher scores indicate better functionality.
Baseline and Week 4
AI-Based Exercise Adherence Score
Periodo de tiempo: During each of the 12 sessions over the 4-week intervention period
In the intervention group, the application automatically calculates an AI-based adherence score as the percentage of predefined exercise criteria met during each session. Scores range from 0 to 100%, with higher scores indicating better adherence to the required exercise form.
During each of the 12 sessions over the 4-week intervention period
AI-Based Landmark Coverage Ratio
Periodo de tiempo: During each of the 12 sessions over the 4-week intervention period
In the intervention group, the application calculates a landmark coverage ratio as the percentage of required body landmarks detected by the camera during each exercise. Scores range from 0 to 100%, with higher scores indicating better camera-based landmark detection.
During each of the 12 sessions over the 4-week intervention period

Otras medidas de resultado

Medida de resultado
Medida Descripción
Periodo de tiempo
Immediate Change in Session-Level Pain/Tension Intensity
Periodo de tiempo: Immediately before and after each session during the 4-week intervention period
In the intervention group, pain/tension intensity is recorded immediately before and after each progressive muscle relaxation session using a 0-10 Visual Analog Scale. The immediate session-level change is calculated as post-session score minus pre-session score.
Immediately before and after each session during the 4-week intervention period

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

8 de abril de 2026

Finalización primaria (Actual)

13 de mayo de 2026

Finalización del estudio (Actual)

13 de mayo de 2026

Fechas de registro del estudio

Enviado por primera vez

30 de abril de 2026

Primero enviado que cumplió con los criterios de control de calidad

30 de abril de 2026

Publicado por primera vez (Actual)

7 de mayo de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

20 de mayo de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

17 de mayo de 2026

Última verificación

1 de mayo de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Descripción del plan IPD

Individual participant data will not be publicly shared due to ethical approval conditions and personal data protection requirements. De-identified aggregate data may be made available from the corresponding investigator upon reasonable request, subject to institutional and ethics approval.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir